Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-20-008721
Filing Date
2020-04-13
Accepted
2020-04-13 16:24:46
Documents
1
Period of Report
2020-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 2358
  Complete submission text file 0001140361-20-008721.txt   3891
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Issuer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address MAX-EYTH-STRASSE 42 HOLZGERLINGEN 2M 71088
Business Address MAX-EYTH-STRASSE 42 HOLZGERLINGEN 2M 71088 49-0-7031-49195-10
Curetis N.V. in Liquidation (Reporting) CIK: 0001809183 (see all company filings)

State of Incorp.: P7
Type: 3 | Act: 34 | File No.: 001-37367 | Film No.: 20789011